Heparanase activity and bone loss in postmenopausal breast cancer patients.
Altundag
Kadri
K
Altundag
Ozden
O
Baptista
Mauricio Z
MZ
Akyurek
Serap
S
D000730:Androstadienes / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000188:drug therapy / Q000201:enzymology; D001943:Breast Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D005260:Female; D005966:Glucuronidase / Q000378:metabolism*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000201:enzymology*; D017698:Postmenopause; D000099175:Heparanase
D000730:Androstadienes; D047072:Aromatase Inhibitors; D005966:Glucuronidase; D000099175:Heparanase